Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer

Sponsor

Mayo Clinic (Other)

Overall Status

Completed

CT.gov ID

NCT02132325

Collaborator

(none)

Enrollment

Location

Arm

46.2

Duration (Months)

0.4

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study will evaluate feasibility and acceptability of providing the Dignity Therapy/Life Plan intervention to pancreatic or advanced lung cancer patients presenting for treatment in the outpatient medical oncology setting. Investigators hypothesize that providing dignity therapy to this population will be feasible.

Condition or Disease	Intervention/Treatment	Phase
Pancreatic Cancer Non-Small-Cell Lung Cancer	Behavioral: Dignity Therapy	N/A

Study Design

Study Type:

Interventional

Actual Enrollment :

19 participants

Allocation:

N/A

Intervention Model:

Single Group Assignment

Masking:

None (Open Label)

Primary Purpose:

Supportive Care

Official Title:

Phase I/IIA: Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer

Study Start Date :

Apr 1, 2014

Actual Primary Completion Date :

Feb 5, 2018

Actual Study Completion Date :

Feb 5, 2018

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Dignity Therapy	Behavioral: Dignity Therapy Dignity Therapy/Life Plan will be provided by an advanced practice nurse or chaplain (APN/Chap), who has undergone training in provision of Dignity Therapy (offered through a 3-day group workshop by Dr. Harvey Chochinov).

Arm

Intervention/Treatment

Experimental: Dignity Therapy

Behavioral: Dignity Therapy

Dignity Therapy/Life Plan will be provided by an advanced practice nurse or chaplain (APN/Chap), who has undergone training in provision of Dignity Therapy (offered through a 3-day group workshop by Dr. Harvey Chochinov).

Outcome Measures

Primary Outcome Measures

Change in level of distress as measured by distress scores on the Distress Thermometer [Baseline & at the end of the dignity therapy intervention (approximately 6 weeks)]

Eligibility Criteria

Criteria

Ages Eligible for Study:

19 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Age >18
Undergoing chemotherapy for pancreatic adenocarcinoma or advanced NSCLC (pancreatic arm closed)
English-speaking
Cognitively intact, per clinician judgment, as documented in electronic medical record (EMR)

Exclusion Criteria:

Currently receiving hospice or palliative care services
Concurrent diagnosis of delirium or dementia, per medical record
Diagnosis of major depression disorder, acute anxiety disorder or schizophrenia per medical record
Participating in other psychosocial intervention research studies.